PortfoliosLab logoPortfoliosLab logo
PAHC vs. APH
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

PAHC vs. APH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Phibro Animal Health Corporation (PAHC) and Amphenol Corporation (APH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

PAHC vs. APH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PAHC
Phibro Animal Health Corporation
48.39%80.76%86.30%-10.42%-32.33%7.28%-20.09%-21.31%-3.00%15.75%
APH
Amphenol Corporation
-6.32%96.08%41.30%31.85%-11.96%35.25%22.09%34.91%-6.82%31.81%

Fundamentals

Market Cap

PAHC:

$2.27B

APH:

$162.83B

EPS

PAHC:

$2.25

APH:

$3.34

PE Ratio

PAHC:

24.53

APH:

37.88

PEG Ratio

PAHC:

0.06

APH:

1.26

PS Ratio

PAHC:

1.54

APH:

7.00

PB Ratio

PAHC:

6.82

APH:

12.14

Total Revenue (TTM)

PAHC:

$1.46B

APH:

$23.09B

Gross Profit (TTM)

PAHC:

$467.02M

APH:

$8.52B

EBITDA (TTM)

PAHC:

$209.00M

APH:

$6.89B

Returns By Period

In the year-to-date period, PAHC achieves a 48.39% return, which is significantly higher than APH's -6.32% return. Over the past 10 years, PAHC has underperformed APH with an annualized return of 9.53%, while APH has yielded a comparatively higher 25.30% annualized return.


PAHC

1D
3.67%
1M
1.55%
YTD
48.39%
6M
37.39%
1Y
162.39%
3Y*
57.25%
5Y*
20.22%
10Y*
9.53%

APH

1D
6.04%
1M
-13.32%
YTD
-6.32%
6M
2.50%
1Y
94.00%
3Y*
46.92%
5Y*
31.66%
10Y*
25.30%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PAHC vs. APH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PAHC
PAHC Risk / Return Rank: 9696
Overall Rank
PAHC Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
PAHC Sortino Ratio Rank: 9797
Sortino Ratio Rank
PAHC Omega Ratio Rank: 9494
Omega Ratio Rank
PAHC Calmar Ratio Rank: 9696
Calmar Ratio Rank
PAHC Martin Ratio Rank: 9696
Martin Ratio Rank

APH
APH Risk / Return Rank: 9090
Overall Rank
APH Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
APH Sortino Ratio Rank: 8989
Sortino Ratio Rank
APH Omega Ratio Rank: 9191
Omega Ratio Rank
APH Calmar Ratio Rank: 8787
Calmar Ratio Rank
APH Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PAHC vs. APH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Phibro Animal Health Corporation (PAHC) and Amphenol Corporation (APH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PAHCAPHDifference

Sharpe ratio

Return per unit of total volatility

3.09

2.30

+0.78

Sortino ratio

Return per unit of downside risk

3.96

2.65

+1.31

Omega ratio

Gain probability vs. loss probability

1.48

1.40

+0.08

Calmar ratio

Return relative to maximum drawdown

6.51

3.23

+3.28

Martin ratio

Return relative to average drawdown

17.67

11.34

+6.32

PAHC vs. APH - Sharpe Ratio Comparison

The current PAHC Sharpe Ratio is 3.09, which is higher than the APH Sharpe Ratio of 2.30. The chart below compares the historical Sharpe Ratios of PAHC and APH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


PAHCAPHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.09

2.30

+0.78

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.45

1.08

-0.63

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.22

0.93

-0.72

Sharpe Ratio (All Time)

Calculated using the full available price history

0.29

0.62

-0.33

Correlation

The correlation between PAHC and APH is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

PAHC vs. APH - Dividend Comparison

PAHC's dividend yield for the trailing twelve months is around 0.87%, more than APH's 0.66% yield.


TTM20252024202320222021202020192018201720162015
PAHC
Phibro Animal Health Corporation
0.87%1.28%2.29%4.15%3.58%2.35%2.47%1.93%1.31%1.19%1.37%1.33%
APH
Amphenol Corporation
0.66%0.55%0.79%1.07%1.06%0.89%0.80%0.89%1.09%0.80%0.86%1.01%

Drawdowns

PAHC vs. APH - Drawdown Comparison

The maximum PAHC drawdown since its inception was -79.62%, which is greater than APH's maximum drawdown of -63.41%. Use the drawdown chart below to compare losses from any high point for PAHC and APH.


Loading graphics...

Drawdown Indicators


PAHCAPHDifference

Max Drawdown

Largest peak-to-trough decline

-79.62%

-63.41%

-16.21%

Max Drawdown (1Y)

Largest decline over 1 year

-24.76%

-28.19%

+3.43%

Max Drawdown (5Y)

Largest decline over 5 years

-65.71%

-28.73%

-36.98%

Max Drawdown (10Y)

Largest decline over 10 years

-79.62%

-37.56%

-42.06%

Current Drawdown

Current decline from peak

-2.98%

-23.85%

+20.87%

Average Drawdown

Average peak-to-trough decline

-39.25%

-13.55%

-25.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.12%

8.03%

+1.09%

Volatility

PAHC vs. APH - Volatility Comparison

Phibro Animal Health Corporation (PAHC) and Amphenol Corporation (APH) have volatilities of 13.78% and 14.30%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


PAHCAPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.78%

14.30%

-0.52%

Volatility (6M)

Calculated over the trailing 6-month period

34.47%

33.98%

+0.49%

Volatility (1Y)

Calculated over the trailing 1-year period

52.95%

41.10%

+11.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.85%

29.47%

+15.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

43.68%

27.16%

+16.52%

Financials

PAHC vs. APH - Financials Comparison

This section allows you to compare key financial metrics between Phibro Animal Health Corporation and Amphenol Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
373.91M
6.44B
(PAHC) Total Revenue
(APH) Total Revenue
Values in USD except per share items

PAHC vs. APH - Profitability Comparison

The chart below illustrates the profitability comparison between Phibro Animal Health Corporation and Amphenol Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%32.0%34.0%36.0%38.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
35.5%
38.2%
Portfolio components
PAHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Phibro Animal Health Corporation reported a gross profit of 132.66M and revenue of 373.91M. Therefore, the gross margin over that period was 35.5%.

APH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Amphenol Corporation reported a gross profit of 2.46B and revenue of 6.44B. Therefore, the gross margin over that period was 38.2%.

PAHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Phibro Animal Health Corporation reported an operating income of 50.33M and revenue of 373.91M, resulting in an operating margin of 13.5%.

APH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Amphenol Corporation reported an operating income of 1.77B and revenue of 6.44B, resulting in an operating margin of 27.5%.

PAHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Phibro Animal Health Corporation reported a net income of 27.46M and revenue of 373.91M, resulting in a net margin of 7.3%.

APH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Amphenol Corporation reported a net income of 1.20B and revenue of 6.44B, resulting in a net margin of 18.6%.